Reeve Emma bought PTCT
November 12, 2025 · Form 4 insider transaction
Reeve Emma bought 7,333 shares of PTC Therapeutics, Inc. at $46.54 per share, a transaction worth $341.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,333
Price
$46.54
Total value
$341.3K
InsiderReeve Emma
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 12, 2025
Filing dateNovember 14, 2025
Shares owned after13,999
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2025.